China has become the first country in the world to approve Roche’s anti-complement C5 antibody crovalimab, the only treatment for the rare disorder paroxysmal nocturnal haemoglobinuria (PNH ...
Four years ago, five Haitian police officers, Pierre Lucdor, Alexis Vivender, Desilus Wislet, Eugene Stanley, and Patrick ...
Regeneron will have a tough job taking on AstraZeneca’s big-selling Ultomiris in the market for paroxysmal nocturnal haemoglobinuria (PNH) therapies – but new biomarker data suggests it could ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback